Furthermore, we performed an extensive phenotypic comparative analysis of the expression of the two target genes in a panel of human breast cancers classified according to Sotiriou and Pusztai [22] as the subtypes luminal A, luminal B, HER-2 and triple negative, and by non breast tumors over expressing ErbB-2. This evidence concerns the gene ERBB2 and breast carcinoma.